Key result
Radiological sarcopenia, measured by the PM:L3 ratio, was significantly associated with 30-, 90-, and 365-day mortality in patients undergoing emergency laparotomy (P<0.001).
Why the study?
Established surgical risk assessment tools are accurate but limited by multicomponent complexity, prompting evaluation of whether a simple measure of radiological sarcopenia predicts mortality in emergency laparotomy patients.
Does radiological sarcopenia predict mortality in patients undergoing emergency laparotomy?
Cohort (n=500)
Yes
Does radiological sarcopenia predict mortality in patients undergoing emergency laparotomy?
p-value: p=<0.001
A simple CT-based measure of radiological sarcopenia (PM:L3 ratio) is a significant predictor of mortality in emergency laparotomy patients, performing comparably to complex established risk assessment tools.
May support preoperative risk stratification in emergency laparotomy; hypothesis-generating and requires prospective validation before practice change.
BACKGROUND: Emergency Laparotomy (EL) is recognized as high-risk surgery with high mortality. Established surgical risk assessment tools (NELA Risk Prediction Calculator, P-POSSUM, ACS-NSQIP) are accurate predictors of morbidity and mortality. However, their multicomponent complexity limits their use in practice. Sarcopenia is associated with poorer surgical outcomes. This study tests for an association between a simple measure of radiological sarcopenia and mortality in EL patients in an Australian cohort. METHODS: A retrospective analysis was conducted of 500 patients admitted to four Australian hospitals who underwent EL during 2016-2017. All patients had a contemporaneous abdomino-pelvic CT scan. Radiological sarcopenia was measured as the ratio of total psoas muscle area (PM) to L3 vertebral body cross sectional area (PM:L3). Patients were followed up to 12 months. Primary outcomes were 30-, 90- and 365-day mortality. RESULTS: The mean 30-day mortality predictions for NELA, P-POSSUM and ACS-NSQIP were 11.36%, 17.28% and 11.30% respectively. PM:L3 ratio was associated with 30-, 90- and 365-day mortality (P < 0.001) and sex (P < 0.001) and negatively correlated with age (r = -0.4612; P < 0.001). Radiological sarcopenia had a weak negative correlation with NELA (r = -0.2737; P < 0.001), P-POSSUM (r = -0.1880; P < 0.001) and ACS-NSQIP (r = -0.2351; P < 0.001). The latter three metrics were significantly correlated (r > 0.5696; P < 0.001). CONCLUSION: Radiological sarcopenia (CT-assessed PM:L3) is a significant predictor of mortality in EL patients in Australia. The results of this study suggest that radiological sarcopenia is equivalent to established risk assessment tools. The more timely and easily accessible CT-assessed PM:L3 metric is potentially automatable and may have significant utility in clinical practice.
No takes yet. Share an insight, caveat, or question.
Ming et al. (2022) conducted a cohort in Emergency Laparotomy (n=500). Radiological sarcopenia (PM:L3 ratio) was evaluated on 30-, 90- and 365-day mortality (p=<0.001). Radiological sarcopenia, measured by the PM:L3 ratio, was significantly associated with 30-, 90-, and 365-day mortality in patients undergoing emergency laparotomy (P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: